Alphabet’s life sciences business Verily is restructuring as a new corporate entity and raising money. Verily announced that with its $300 million investment round, it would convert from an LLC to a corporation and rename itself Verily Health Inc. As a result, Alphabet now has a minority stake rather than a controlling stake in the business.
Like every other tech business, this chapter of Verily will focus on AI. Chairman and CEO Stephen Gillette said, “From research to care, our customers need solutions that bring the best of clinical and scientific rigor with AI to deliver next-generation health care – that is as personalized as it is precise.”
Google Life Sciences was renamed Verily in 2015, around the same time that Google also rebranded to Alphabet. It has worked on a wide range of projects over the years, such as using eye scans to predict heart disease and an opioid addiction center. In 2025, it shut down its medical device division, a move that would have signaled its shift toward AI.
<a href